Women's Health Problems

Emergency contraception less accessible accurately, say researchers: Serious and pricey barriers remain
Efforts to get rid of barriers to being able to access emergency contraception (EC) scored victories in 2013, once the U.S. Fda removed age limitations on over-the-counter sales from the levonogestrel drug Plan B. But individuals who require EC can continue to encounter cost and availability barriers.
Researchers in the College of Colorado Med school discovered this once they requested 633 Colorado pharmacies in 2014 about EC access. They found EC completely available to just 23 percent of individuals using them.
They report their findings within the latest publication of the journal Women's Health Problems , "Barriers to Single-Dose Levonorgestrel-Only Emergency Contraception Access in Retail Pharmacies." The research was selected through the editor of Women's Health Problems being an Editor's Choice article for that September/October 2017 edition.

Women's Health Problems may be the official journal from the Jacobs Institute of Women's Health, that is located in the Department of Health Policy and Management at Milken Institute School of Public Health (Milken Institute SPH) in the George Washington College.
Study author Van (Mimi) Chau, students at CU Med school, underneath the mentorship of Carol Stamm, MD, together with colleagues that incorporated Laura Borgelt, PharmD, a professor in the College of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences used the small Blue Book 2014, which physicians use for referrals, to recognize Colorado pharmacies, after which had three researchers call the pharmacies pretending to be women seeking levonogestrel-only emergency contraception (LNG-EC). Chau was area of the University's Leadership, Education, Advocacy and Development (LEADS) track while she labored around the project.